Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: OmniAb Inc., 3 years.
OmniAb Inc.
Director
Contineum Therapeutics Inc.
Director
Atrium Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Contineum Therapeutics Inc. June 26, 202595.2%
-
OmniAb Inc. June 18, 202475.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 18, 2026 | Atrium Therapeutics Inc. | Shares withheld for tax | −126,418 | $8.95 | $1,131,441 |
| Jun 18, 2024 | OmniAb Inc. | Option exercise | +20,000 | — | — |
| Jan 30, 2023 | OmniAb Inc. | Grant or award | +8,753 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.